Journal of Urologic Oncology

Search

Page Path

HOME
Search

Clinical Predictors of ARTA Response in Metastatic Prostate Cancer

Topic Article

Predictive Factors of Abiraterone Response in Patients With High-Risk Metastatic Hormone-Sensitive Prostate Cancer: Jaeyoung Cho, Jungyo Suh, Dalsan You, In Gab Jeong, Jun Hyuk Hong, Hanjong Ahn, Bumjin Lim; Journal of Urologic Oncology. 2023;21(3):257-263. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234604600023
Cited By 1; Full text PubReader ePub PDF

Original Article

Value of the New 5-Tiered Prostate Cancer Grade Group System on Predicting Oncological Outcomes for Radical Prostatectomy Population in Korea: Minhyun Cho, Sangjun Yoo, Juhyun Park, Chang Wook Jeong, Ja Hyeon Ku, Cheol Kwak, Hyeon Hoe Kim, Min Chul Cho, Hyeon Jeong; Korean J Urol Oncol. 2018;16(2):75-81. Published online August 31, 2018; DOI: https://doi.org/10.22465/kjuo.2018.16.2.75
Cited By 1; Full text PubReader ePub PDF

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043

MOST READ MOST CITED

5,199	Complex Epidemiology of Prostate Cancer in Asian Countries
3,583	Current Update on Prostate Cancer Immunotherapy
3,251	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
3,176	Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up
3,049	Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023

Cited By 10	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 7	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 2	A Cost-Benefit Comparison of Biparametric Magnetic Resonance Imaging Versus Conventional Prostate Cancer Screening
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use

Editorial Office: Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817, FAX: +82-2-742-4665 Email: journal@e-juo.org

Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: leeseh@yuhs.ac

Copyright © The Korean Urological Oncology Society.